Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Flindr Therapeutics Flindr develops first-in-class precision oncology therapies identified through the Immunogram Drug Discovery Engine Flindr Therapeutics, based in Oss in the Netherlands, is a private pre-clinical biotech company developing next-generation precision oncology treatments. The Company, previously called Immagene, was spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute in 2020, by founders Prof Daniel Peeper, Prof Christian Blank and Dr Maarten Ligtenberg. Flindr is actively building a pipeline of highly promising, first-in-class precision oncology therapies identified through the ImmunoGram Drug Discovery Engine. It is backed by V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Sareum Ltd Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases and has entered Phase 1a/b clinical development with an initial focus on psoriasis. Sareum has an economic interest in SRA737, a clinical-stage Chk1 inhibitor which it originally developed in collaboration with several Cancer Research UK-related organisations. SRA737 has shown … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
DelSiTech Ltd The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 52 | |
Blatchford "Creating the future of mobility to realise dreams" #MobilityMadePossible We are a multi-award winning manufacturer of some of the world's most advanced prosthetic technology, bespoke seating solutions and orthotic devices. We combine clinical expertise and pioneering innovation to redefine mobility. Our evidence-based approach and commitment to continuously challenging possibilities ensures our mobility solutions prioritise the health and long-term health of our users. Through science, technology, and a clear focus on people, we make mobility possible. Lower limb prosthetic products, Prosthetic Service, Orthotic Service, Special Seating, Private Clinic, Clinical Studies, Carbon Fibre Technology, Microprocessor Technology, Medical Devices, Medical Technology, Specialist Rehabilitation, … Type: SMB Activities: healthtech deeptech transporttech manufacturing Technologies: Synthetic Biology | 4 | 1 | 3 | 490 | |
ARC GROUP UK ARC Medical // ARC Rail Training // ARC Plant and Civils Training Experienced, established, trusted and proven... We are specialists in Rail Training, Plant & Civils Training, Health Safety Training and also Medicals and Drug & Alcohol Screenings. ARC has grown into a group of four companies, recognised largely as a leading Training Provider with training centres in South Wales and London. From our early beginnings as a dedicated Rail Training provider, we have evolved into a multi-faceted, national provider of: - Rail Training - Rail Apprentices - Medicals and Drug & Alcohol Screening - Occupational Health & Safety Training … Type: SMB Activities: edtech Technologies: Synthetic Biology | 0 | 0 | 0 | 37 | |
Medicrea Pioneering the digital transformation of spinal surgery through A.I., predictive modeling and patient-specific implants. Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing … Type: SMB Activities: biotech deeptech healthtech manufacturing Technologies: 3D Printing A.I. A.I. - Machine Learning Synthetic Biology | 1 | 1 | 0 | 70 | |
Nicox Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 51 | |
STELLA SURGICAL [Automatic translation follows] The new way of transplantation Stella Surgical is a European company based in the South of France. It was created to meet the needs of transplant surgeons, organ harvesting and transplant teams, and organ transporters. Our promise: to increase the number of available grafts, and their safety throughout the entire transplant process. Thus, we design, develop and market connected and innovative medical devices so that coordination teams (harvesting and transplant) can plan transplants in the best possible conditions. Patients will therefore be able to benefit from better conditions during their transplant. Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 2 | 6 | 6 | |
Biospace Lab Imaging for discoveries Molecular Imaging in Real Time Biospace Lab - originally Biospace Mesures - was founded in 1989 by Nobel Prize winner Georges Charpak to provide fellow researchers in biology with innovative imaging tools based on his discoveries in high-energy physics and particle detection. Since then, Biospace Lab has pursued and created strong links with medical, pharmaceutical and scientific communities to bring relevant and creative solutions to biomedical imaging needs. Today, Biospace Lab range of instruments, developed with patented technologies, is dedicated to high-performance imaging for pre-clinical research in drug discovery and biology. Biospace Lab instruments and software are … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 3 | 14 | |
Plastomics, Inc. Plastomics is developing next generation trait delivery technology that leverages the power of chloroplasts. Plastomics' novel trait delivery technology harnesses the power of the plant cell to create crops than can better withstand the pressure of insects, diseases and weeds and that are more efficient and deliver higher yields. Plastomics technology will give seed companies the benefits of simplified product development, more effective products and new market opportunities. plant transformation, chloroplast transformation, agricultural biotechnology, soybean transformation, and corn transformation Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 27 | |
Immunophotonics, Inc. Interventional Immuno-Oncology Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their … Type: Startup Activities: legaltech biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 18 | |
Future Fields We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a … Type: Startup Activities: agritech Technologies: Synthetic Biology | 6 | 0 | 5 | 43 | |
CeQur Our mission is to simplify the lives of people with diabetes CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 113 | |
AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 11 | 1 | 4 | 585 | |
Assay Genie Creating World-Class Assays, Immunoassays, Antibodies & Proteins Assay Genie is a global life reagents company with over 120,000 products including immunoassays, antibodies, proteins & activity assays for research and development scientists. Founded in 2017, Assay Genie has offices in Dublin, Ireland & London, UK. With distributors in over 70 countries, Assay Genie works with scientists all around the World and counts Pfizer, J&J, Harvard University and many more of the World’s leading companies & universities among its customers. Company Achievements & Core Technologies Since its inception in 2017, Assay Genie has gone form strength-to-strength. The company began by building a … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 18 | |
Habitual Type 2 diabetes care, reimagined. Weight loss is just the beginning. ⚖️ Clinically proven weight loss programmes with total diet replacement and medication 📱 App-based tracking, expert-written behaviour change content, professional and peer support. 🌈 NHS diabetes remission partnerships 🔬 Active clinical research 👉 www.tryhabitual.com Type: Startup Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 24 | |
Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 4 | 6 | 119 | |
BioLogos BioLogos explores God’s Word and God’s World to inspire authentic faith for today. BioLogos explores God’s Word and God’s World to inspire authentic faith for today. evolution, creationism, intelligent design, biblical scholarship, genetics, cell biology, christianity, jesus, theology, creation care, bioethics, christian ethics, and human identity Type: Startup Activities: biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 33 | |
Auto21 [Automatic translation follows] Cars and mobility of the 21st century Type: Startup Activities: transporttech Technologies: Synthetic Biology | 1 | 0 | 0 | N/A | |
UserWise [ClariMed, Inc.] UserWise is now ClariMed. Uniting global expertise in medical product development and regulatory services. At ClariMed we are clarifying the pathway for usable medical products. We are a human-centered medical device development and regulatory services company accelerating time to market, improving safety, and enabling innovation for pharma and medtech teams while enhancing outcomes and enriching the quality of life for their users. Through embedding human factors and other user focused and risk-mitigated services we partner with our clients to develop innovative medical technologies and make them accessible to the communities who need them. Industries served: Pharma, Biotech, Medtech/device Services offered: … Type: Startup Activities: deeptech it services Technologies: Synthetic Biology | 0 | 0 | 0 | 68 | |
CytoReason The First Cell-Centered Computational Model of Human Disease CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 7 | 1 | 4 | 135 | |
Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 51 | |
PainNavigator Digital therapy platform for pain management providers - remote care & billing for patients with chronic pain. PainNavigator is a digital therapy platform that supports tracking patient outcomes & unlocks remote care & billing for pain management providers. PainNavigator provides an accessible and evidence-based interdisciplinary therapeutic program for patients with acute and chronic nonsurgical pain. Type: Startup Activities: healthtech deeptech Technologies: SaaS Synthetic Biology | 0 | 0 | 0 | 9 | |
CS MEDICA Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Cellbox Solutions LIVE CELL SHIPMENT Cellbox Solutions is a young technology company focusing on delivering innovative and new solutions for the correct handling of living cells and biologic structures. Our product Cellbox is a self-sustaining carbon dioxide incubator supporting the appropriate storage, reproduction, transportation and analysis of biologic materials. The incubator’s temperature and gas environment can be adjusted based on the biosphere necessary for the cultivating cells stored. Biotechnology, Cell Transportation, Temperature Regulation, BioTech, Logistics, CO2 Solutions, Cell Cultures, Biological Structures, Preclinical Services, Live cell transport, portable CO2 incubator, and portable incubator Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 3 | 22 | |
Virax Biolabs Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. medical device development, medical device distribution, Logistics, Procurement, Distribution, IOTH, Innovation, T-Cells, and immunology Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 25 | |
Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 2 | 22 | |
ByoRNA The future of mRNA bioproduction. ByoRNA uses eucaryotic cells as natural biofactories to make high-quality messenger RNA (mRNAs). Our bioproduction technology will help mass produce mRNA and enhance productivity at a fraction of the current cost. By perfecting an overlooked mRNA production method, we are helping build a more sustainable planet, save cancer patients and give their grand-children a future. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 3 | 5 | 8 | |
Osta Therapeutics Developing Smart Molecules Against Superbugs Type: Startup Activities: deeptech Technologies: Synthetic Biology IoT | 9 | 4 | 4 | 3 | |
PharmaZell We supply the world with active pharmaceutical ingredients. PharmaZell offers a focused portfolio of small molecule APIs, together with custom development and manufacturing services for the generic and originator pharmaceutical industry. The company operates at three production sites, one in Germany and two in India. As part of the PharmaZell Group, the company employs 750 employees worldwide. Developing route of synthesis for API´s. Generic or NCE. Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 0 | 328 | |
Synbio Technologies Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 27 | |
Remilk Real Dairy. No Cows. Here at Remilk, we’ve made it our mission to create real dairy without a single cow, bringing a message of hope and joy to our planet, our body... and cows! Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 2 | 0 | 93 | |
Brevel Sustainable protein for the future of our planet Providing sustainable protein for a better future on this planet. Brevel's unique microalgae based protein is flavor and color neutral, has a full amino-acid profile, is highly functional and is affordable for the food industry. Thanks to our breakthrough technology, we introduce a paradigm shift to the microalgae and the plant based protein industries. Microalgae, Mixotrophy, Photobioreactor, Cultivation technology, Alternative protein, Protein, Dairy Alternatives, Egg Alternatives, and Meat Alternatives Type: Startup Activities: biotech agritech Technologies: Synthetic Biology | 3 | 2 | 2 | 36 | |
Nanofaber Srl Advanced Nanotechnologies A nanobiotechnology and smart polymers company. The company is committed to products for several engineering the biomedical sectors, with an emphasis on tissue engineering, drug delivery and functionalized electrospun nanofibers. Nanofaber Srl is the exclusive distributor on the Italian soil of Bioinicia Fluidnatek Slu, leader company in Europe regarding the electrospinning equipment and services. Through its high-specialized division, Nanofaber can offer to its clients premium equipment, services and commercial/technical assistance on the electrospinning and electrospraying technology. nanofibers, SERS, oncoproteins, and nanomechanics Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 6 | |
SpacePharma Bring your research idea and we will make it happen SpacePharma is a unique powerhouse offering an affordable and accessible microgravity research, together with true innovation to R&D pipelines. Our mission is to become a world leader in providing simplified and valuable, end-to-end microgravity services and solutions for research. Microgravity is a disruptive opportunity for several major sectors: pharmaceuticals, biotechnology, chemistry and materials science. It provides companies and researchers with the ability to accelerate discovery processes for new drugs and vaccines, develop new crystals and materials and accelerate the study of human genome and origin of diseases. The potential scientific, … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 5 | 0 | 18 | |
Happy Ocean Foods Tasty and nutritious plant-based seafood. Better for you & the oceans. 🌊 Happy Ocean Foods is one of the leading foodtech startups in the space of plant-based seafood, focusing on utilizing simple and functional ingredients to develop sustainable seafood alternatives. With our tasty and nutritious products we aim to restore the ecological balance in the oceans. We love nature and are passionate about a healthy lifestyle and really good food. We believe that every single one of us is able to make a difference in this world. If we change something in our behavior, this will automatically affect our immediate … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 6 | 2 | 5 | 7 | |
ARRAYS FOR CELL NANODEVICES, SL - A4CELL Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 17 | |
Aidplex MedTech Startup providing innovative solutions in orthopedics Aidplex is an orthopedics company whose patient-centric products are revolutionizing the treatment and monitoring of orthopedic patients. Starting with Scoliosis treatment, Aidplex launched ScolioSense. ScolioSense is a patent-pending medical device designed to ensure the quality of scoliosis treatment by combining portability, accuracy, and assurance of the correct fitting of the back brace. Orthopedics, HealthTech, Patient-Centric solutions, Rehabilitation, scoliosis, medical devices, and quality assurance Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 8 | |
Interreg Mattisse [Automatic translation follows] 3D matrices for tissue reconstruction Application to breast reconstruction The MAT(T)ISSE project proposes to create a new bioprosthesis, a class 3 implantable medical device, which aims to help the body restore damaged areas following curative surgical procedures. This tissue restoration is done by autologous removal of fat cells (adipose tissue) reimplanted on a synthetic and resorbable lace-type textile structure. The textile structure has a role of support, helping the implanted fat cells to multiply and revascularization. It is coupled with a bioresorbable and personalized 3D shell that delimits the volume to be reconstructed. Eventually, the resorbable support … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | N/A | |
Perpetua Medical AB Serial acquirer in the Healthcare sector Welcome to Perpetua Medical! We are an acquirer of profitable businesses in the healthcare sector, applying a decentralized and long-term ownership model. If you are considering selling your business, please contact us through our website. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Matrix Requirements Focus on medical device design, not on paperwork! We are also ISO27001 and ISO13485 certified. Matrix Requirements GmbH is a global software leader helping innovative Medical Device companies remain focused on developing safer products faster. MatrixALM & MatrixQMS reduce the regulatory burden by bridging the gap between agile & compliance to ensure quality across the entire product lifecycle. Matrix Requirements is an EN ISO 13485:2016 and ISO/IEC 27001:2013 certified company. Visit www.matrixreq.com for information. Requirements, Specifications, Traceability, Cloud, Software documentation, ISO13485, ALM, QMS, Risk Management, Controlled Documents, Medical Devices, Medical Device, Medical Device Regulation, Medical Device Software, Medical Device Requirements … Type: Startup Activities: deeptech healthtech it services Technologies: SaaS Synthetic Biology | 3 | 2 | 1 | 36 | |
Axol Bioscience Ltd. World leaders in iPSC technology supporting the next generation of advanced models for drug discovery We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas. As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services. Our industry-leading iPSC capabilities support the pursuit … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 49 | |
Rigenerand srl Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 5 | |
Ncardia Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster. Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 62 | |
Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 2 | 9 | |
Pixacare Turning smartphones into powerful medical devices 📲 Medical photo management, Wound management, Artificial intelligence "Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 25 | 8 | 18 | 26 | |
EverImmune Harnessing the microbiome for the development of diagnosis and therapeutic tools in cancer ! EverImmune is a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology. It harnesses the gut microbiota for the development of a unique approach aiming to restore the response of Immune Checkpoint Inhibitors (ICIs) in cancer patients. The company is developing Oncobax AK, a Live Biotherapeutic Product (LBP) used as an oral adjuvant to anticancer immunotherapies, designed to safely boost the immune system and restore sensitivity to immunotherapies in primary resistance settings. The company also develops other bacteria in … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 4 | |
Ski-Mojo Ski-Mojo exoskeleton is a life changing technology for all skiers, not only for those with knee pain. Ski-Mojo manufactures the best and more affordable snow sports dedicated exoskeleton. The Ski-Mojo allows skiers, snowboarders, telemarker, skwalers to ride stronger, faster, better, longer with less muscles knee and back pain. It gives more power to the rider, provides more safety and more pleasure. The Ski-Mojo, it's your legs but better. Ski-Mojo fabrique et distribue le meilleur exosquelette dédié aux sports de glisse. Le Ski-Mojo permet aux skieurs, snowboarders, télémarkeurs, skwaleurs de rider plus fort, plus vite, plus longtemps tout en réduisant la … Type: Startup Activities: manufacturing sporttech Technologies: Synthetic Biology | 10 | 1 | 9 | 11 | |
Bioparhom Your body composition in 1 click ! At the cutting edge of research in the field of bioimpedance, BioparHom designs, produces and markets medical equipment for analyzing body composition. Our goal is to provide health, nutrition and sports professionals, with aesthetics and researchers, with measurement and diagnostic support tools of body composition. The quality of our products is now well established in these markets and we are continuing our research to improve our equipment and provide more and more support for users. In three seconds, reliable indicators are measured, allowing health, nutrition and sports professionals to give an optimal diagnosis … Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 11 | |
Algobiotech [Automatic translation follows] Specializing in the valorization of microalgae, Algobiotech is involved in the selection of new strains and the extraction of molecules of interest up to their exploitation in cosmetic applications, food supplements and therapeutics. Algobiotech aims to develop and market innovative products derived from microalgae for the aforementioned applications. Through its membership in GENOPOLE, the leading French bio cluster in biotechnology, Algobiotech benefits from a very favorable environment to find the right scientific and institutional partners to develop its R&D program around the identification and validation of the biological activities of molecules derived from microalgae. By relying on … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
STANIPHARM Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 12 | |
NVH Medicinal [Automatic translation follows] The synthetic collagen revolution NVH Medicinal, world expert in synthetic collagen NVH Medicinal is a biotechnology company based in Dijon, created at the end of 2008, whose mission is to treat pathologies linked to a collagen deficiency. It develops products derived from collagen, the most abundant protein in the body and whose dysfunctions cause many diseases (aging, cardiovascular, inflammatory, neurological diseases, fibrosis, cancer and rare diseases). NVH's ambition is to be recognized as an innovative player in the treatment of collagen-related diseases by becoming one of the world leaders in the development, production and marketing of a … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Leads To Development Your expert drug development partner, guiding your asset to and through the clinic If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one. At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible. With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are in biotech rather than big pharma, so we understand the … Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 1 | 19 | |
AGV Discovery [Automatic translation follows] AGV Discovery offers services in chemistry, cell biology, in vitro screening, rational drug design, outsourcing and consultancy. AGV Discovery is a pharmaceutical company that specializes in the rational design and early development of drug candidates. Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
BIOGALENYS LABORATOIRE SPÉCIALISÉ DANS LES ÉTUDES DE PERMÉABILITÉ et ANALYSES CHIMIQUES. BIOANALYSIS and BIOPHARMACY - pKa, LogP, LogD, Physiological solubility and stability - in-vitro, in-vivo and ex-vivo assay studies. - Permeability, Absorption, Distribution. - BCS determination. - Franz Cells , Ussing chambers (Skin, Buccal and Nasal mucosa, intestinal segments, corneal and scleral permeability). - Eye distribution and Pharmacokinetic. - In-vitro / in-vivo correlation. ANALYTICAL SERVICES - HPLC-MS-MS ,DAD, UV. - GCMS-EI. - Spectrometry (fluorescence and luminescence), Elisa. COSMETIC SERVICES - Chromatographic qualification and quantification of preservatives (ISO 9001, ISO 22716). - UV filters and vitamin (ISO 9001, ISO 22716). - Actives … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 4 | 9 | 10 | |
Poly-Dtech Enhance your detection Founded in 2019, Poly-Dtech is a French company, based in Strasbourg, specializing in innovative solutions for biomarker detection through an advanced cutting-edge technology: Bright-DtechTM 🎯 OUR MISSION: We aim to enhance current screening, drug discovery, and early disease diagnosis by advancing biomarker detection in scientific research and medical diagnostics. Poly-Dtech develops and produces immunoassays and Lateral Flow tests based on high-performance fluorescent nanoparticles with unique features. 🧪 BRIGHT-DTECHTM TECHNOLOGY: Bright-DtechTM represents a cutting-edge lanthanide-based fluorescent nanoparticles, surpassing existing products by significantly improving biomarker detection across diverse sample types and concentration levels, including previously undetected biomarkers. ⁃ User-friendly … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 7 | 16 | 4 | |
MD101 Consulting for medtech companies : - R&D - Quality assurance - Regulatory affairs - Clinical & Reimbursement strategies MD101 was founded to assist medical device companies in developing and bringing products to market, accelerating time-to-market, and ensuring compliance with regulatory standards. With its large network of experts, MD101 provides mastery in a myriad of medical devices and is equipped to handle whatever challenge a manufacturer is facing, whether it is quality assurance, regulatory affairs, clinical affairs, reimbursement strategy, or international business development. At MD101, we bring you the power of our unique value proposition, focused on healthcare, and the experience … Type: Startup Activities: consulting Technologies: Synthetic Biology | 24 | 10 | 13 | 23 | |
Archeon Medical High-Performance artificial ventilation for the EMS, Hospitals and military organizations. Archeon takes its name from the Acheron river, a tributary of the legendary Styx, which separates the world of the living from Hades, the greek mythological world of the dead. We are a french company made up of people who believe in innovation and in the great opportunities offered by deep technology and artificial intelligence to save lives. Patient Monitoring & Diagnostics, Emergency Care, Critical care devices, Medical devices, Basic & Advanced Life Support, and Cardiopulmonary Resuscitation Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 29 | 8 | 23 | 27 | |
Mnemo Therapeutics Empower the body, cure the disease Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific … Type: Startup Activities: biotech Technologies: Synthetic Biology | 6 | 5 | 3 | 34 | |
Resilience [Automatic translation follows] Better cancer care through digital technology Resilience is a company dedicated to remote monitoring and support for oncology patients whose mission is to better treat cancer. Through synergistic tools intended for patients and those who care for them, Resilience provides a global solution aimed at humanizing, streamlining and personalizing care pathways. The Resilience mobile application supports people affected by cancer on a daily basis to help them better cope with the side effects caused by their treatments and improve their quality of life. Resilience's remote monitoring platform, a class IIa medical device, allows healthcare professionals to better … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 46 | 43 | 29 | 181 | |
Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a pioneering biotechnology company revolutionizing the treatment of patients with neurodegenerative or neurovascular diseases by targeting blood-brain barrier (BBB) dysfunctions and neuroinflammation. In the pathophysiology of various neurological diseases such as stroke, multiple sclerosis, and Parkinson's disease, the hyperactivation of endothelial NMDA receptors (NMDAr) by tissue plasminogen activator (tPA) overexpressed in these patients leads to the degradation of tight junctions and BBB dysfunction, allowing the transmigration of inflammatory cells and toxic molecules into the brain parenchyma, triggering excitotoxicity and neuroinflammation, major contributors to neurodegeneration. Lys Therapeutics' lead … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 20 | 5 | 14 | 12 | |
HEMOFAB [Automatic translation follows] Live beyond Dialysis HEMOFAB is a startup specializing in the research, development and marketing of innovative medical solutions, aimed at allowing dialysis patients to return to a life as normal and natural as possible. Founded by a former hemodialysis patient, HEMOFAB works closely with hemodialysis experts, including nephrologists, angiologists and specialized nurses. Our medical device, the FAV Protector, was born from a clear observation: there is currently no medically validated solution to protect the arteriovenous fistula after its creation. Patients therefore turn to homemade solutions, often unsuitable, which can lead to increased risks of superinfection. In addition, … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 12 | 4 | 11 | 2 | |
Kezar Life Sciences Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 71 | |
Space Tango Unearth Answers in Microgravity for Humanity Space Tango is an industry leader in automated systems in the pursuit of health and technology manufacturing in space. Since 2017 through a NASA Space Act Agreement, Space Tango provides facilities to support iterative R&D and manufacturing in space. Through an integrated and intuitive approach, Space Tango works alongside its diverse partner base to embrace pathways to on-orbit production yielding valuable and transformational solutions for humanity. Space Tango believes the microgravity environment is a new frontier for discovery and innovation. We are focused on creating a new global market 250 miles up in low … Type: Startup Activities: spacetech Technologies: Synthetic Biology | 2 | 2 | 0 | 30 | |
LifeScience WorldWide LifeScience & Biotech Worldwide Biotech Developments Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 14 | 0 | 14 | 1 | |
Lumatix Biotech EXIST Start-up Project Lumatix Biotech is developing a light-controlled affinity matrix for an effective and rapid isolation of antibodies. Our new chromatography technology is intended to significantly advance antibody manufacturing, particular with regard to product quality as well as economic aspects. To achieve these ambitious goals and become a superior alternative to Protein A chromatography, we combine several proprietary technologies. The key innovation here is an affinity matrix with a light-controlled binding mode. By this means, the operator can easily capture antibodies in any user-defined buffer, making acidic elution obsolete. Have a look at our website for further information and … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
EMA Pharmaceuticals Leading sealing solutions for pharma- and diagnostic applications - Made in France. EMA Pharmaceuticals is a global actor in the development, manufacturing and marketing of sealing solutions for pharmaceutical containers. Specifically focused on closures for parenteral drug applications, EMA Pharmaceuticals currently serve more than 170 production sites of injectable medicine across the 5 continents. Our ambition is to enhance patients’ safety by providing Pharmaceutical Industry worldwide with clean-certified closure systems, manufactured according highest industry standards, ensuring optimal product integrity, drug recognition and ease of use by healthcare workers. Closure Systems for Pharmaceutical Containers, Primary Packaging Materials for Parenteral Drugs, and … Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 39 | |
KNAUER think LC. think KNAUER. We separate molecules and unite people. We are the largest liquid chromatography focused company in the world! We support scientists with analysis and purification of their products. Our customers work in the food safety, chemical and pharmaceutical industries. We believe in science! That's why we support universities worldwide to reach a higher level of education. Our clear focus allows us to offer solutions that only KNAUER can provide. think LC. think KNAUER. Based in Berlin, KNAUER is a medium-sized, owner-managed company that has been serving the sciences since 1962. We develop and manufacture scientific instruments of … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 138 | |
ten23 health Design. Formulate. Deliver. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 4 | 2 | 2 | 164 | |
UMR Right We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft. UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté. We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI). Our main goals: - Characterize the pathogenic or protective immune responses involved in these diseases in order to identify … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 3 | 1 | 36 | |
CREATEMPS [Automatic translation follows] Marking & assembly for precision industries CREATEMPS has specialized for over 25 years in the field of precision marking and assembly, recognized professional in marking on medical devices. Implantable or not, on silicones, polymers, metals and technical textiles, CREATEMPS masters all marking techniques: pad printing, screen printing, laser engraving, microdosing... Marking, Assembly, Milling, Laser, Screen Printing, Medical Devices, Aeronautics, Watchmaking, Pad Printing, Ink, Implantable, Microdosing, Medical, and Iso 13485: 2016 Type: SMB Activities: healthtech deeptech nanotech Technologies: Synthetic Biology | 4 | 4 | 0 | 6 | |
Inside Therapeutics (InsideTx) Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems! At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines. At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production. Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability … Type: Startup Activities: deeptech biotech manufacturing nanotech Technologies: Synthetic Biology SaaS | 19 | 6 | 9 | 12 | |
Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 34 | |
ACM Global Laboratories Delivering state-of-the-art central lab services across the globe ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400 Central Laboratory Testing for Global Clinical Trials, Central Laboratory Services, Clinical Trials Testing, … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 459 | |
FinVector Oy Discover a unique cGMP, in a unique setting, in a unique country. Welcome to FinVector, Kuopio, Finland. Welcome to FinVector, a leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions. FinVector is owned by Ferring Ventures S/A. Learn more: www.finvector.com Instagram: @finvectorians - https://www.instagram.com/finvectorians/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/ GMP, Manufacturing, Biopharmaceuticals, Gene therapy, and Virus production Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 340 | |
Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 14 | 9 | 8 | 197 | |
Teva Santé [Automatic translation follows] Who is Teva Santé? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of drugs, generic or not, allows the treatment of more than 120 pathologies. In France, its drugs concern one prescription out of 12. But Teva's involvement goes well beyond simple drugs. Its action is part of commitments to patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify, understand and master their role, and improve … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 13 | 1 | 10 | 271 | |
STERIMED Infection Control Healthcare Packaging Materials & Traceability Systems for Medical Device Manufacturers & Patient Care Facilities We are a French group, a leader in the manufacture of sterilization packaging for medical device manufacturers, patient care facilities and the pharmaceutical industry. We are experts in both the manufacture of specialty substrates (paper, polybond®, film, etc.) and the production and supply of ready-to-use sterilization packaging and consumables. As such, we guarantee absolute quality control throughout the supply chain for the utmost safety of patients and caregivers. Concerned with a permanent dynamic of innovation, our R&D teams work on customized developments for our customers and … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 12 | 1 | 3 | 215 | |
Stem Genomics Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 10 | |
ExpertsMedTech, Alliance d'experts en santé [Automatic translation follows] The .EMT Alliance supports healthcare professionals from the birth to the success of their projects. The .EMT alliance, a union of recognized players in HealthTech, supports healthcare professionals from the creation of the project to the launch on the market. We intervene at all stages of development and you centralize your actions within the same team of experts in Medtech, Biotech, Pharma, HealthTech. We have created: TALKS! by .emt: 1 annual event dedicated to healthcare professionals with round tables on current topics, keynotes, individual meetings and networking. RISE! with .emt: 2 days of training dedicated to Digital … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 15 | 2 | 14 | 2 | |
Vivasure Medical Ltd. PerQseal® - Minimal Vascular Complications – Simply Delivered Vivasure Medical Ltd. is an ISO 13485 registered medical device company based at Europe’s leading MedTech cluster in Galway, Ireland. Founded in 2009, the company is led by an experienced management team and backed by a syndicate of international venture capital investors and state agencies. The company has developed and patented the world’s first fully absorbable, patch-based closure device specifically designed to seal large-bore arteriotomies in endovascular procedures. Please, refer to our website for further information. Medical Device, Vascular Closure, Design & Development, ISO 13485, and CE Mark Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 39 | |
EV Biotech Accelerating Strain Development with smart use of models. EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 15 | |
Eventum Orthopaedics Ltd Accessible innovation designed to improve patient outcomes Yorkshire based Med Tech company specialising in Orthopaedics. A small company planning on making a big impact ! Orthopaedics, Medical Devices, and Innovation Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Pludi EU #plant #biotech #verticalfarm Biotechnology research and development Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | N/A | |
DNTOX GmbH Safe chemicals for a healthy brain development without animal experiments We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, it is supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 9 | |
Sensius Balanced Treatment Sensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy. Sensius mission is to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, by balancing efficacy with quality of life. medical device, hyperthermia, oncology, head and neck cancer, and thermotherapy Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 10 | |
Viva In Vitro Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients. Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world. Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes. sepsis , IVD, diagnostics, medical devices, biotech, prognosis, stratification, septic shock, acute inflammation, inflammatory diseases, inflammasomes, nlrp3, biomedical, and … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 8 | |
Linari Medical [Automatic translation follows] Technologies for telerehabilitation of neurovisual hemianopsia patients. Linari Medical has patented an innovative technology for remote visual rehabilitation of brain-damaged visually impaired patients called AvDesk. The system consists of a medical device that emits special audio-visual stimuli based on the patient's disease and processes the patient's feedback in the cloud to be analyzed remotely by a specialist. AvDesk is a class I medical device and can be used in medical clinics or even at home. telemedicine, CVI, visually impaired, e-health, visual rehabilitation, visually impaired, hemianopsia, quadrantopsia, telerehabilitation, and healthcare Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 10 | |
Ascend Advanced Therapies Ascend is an advanced therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is gene to GMP partner with deep expertise in advanced therapy development and commercialization. We offer unparalleled collaboration backed by expertise while working to develop your products from the bench through the clinic and beyond. Let’s build the future of advanced therapies together! Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 3 | 118 | |
Nodus Oncology Developing next generation DDR targeting therapies Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area. Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations Oncology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
Valo Therapeutics Ltd Reinventing Cancer Immunotherapy Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 17 | |
Fada Medical Improving the delivery of insulin for people with type 1 diabetes through extended wear devices Fada Medical's mission is to optimize chronic drug therapy, making life easier for the people who need it. Starting with insulin delivery for those with type 1 diabetes, Fada Medical are developing novel diffusion technologies to prevent and negate the causes of early infusion set failure and cannula occlusion that make insulin therapy more difficult. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Telea Telea | An award-winning software that links Speech Therapists and their clients Telea | An award-winning software that links Speech Therapists and their clients to enable therapists to provide at-home speech therapy. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 1 | 0 | 1 | 5 | |
Recolony AG Harnessing the potential of the microbiome to cure cancer Cancer has emerged as a significant global public health concern, imposing a substantial and ever-increasing socioeconomic burden. The gut microbiota has been established as a critical component in regulating host immunomodulation, maintaining cancer immune homeostasis, and modulating the tumor microenvironment. Recolony is pioneering a groundbreaking approach to cancer treatment by harnessing the potential of the human microbiota. They have uncovered a specific mechanism, by which the gut microbiota activates the immune system, revealing a novel target for cancer immunotherapy. Through in-depth analysis of the host-microbiota interactions, they have identified a specific … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 9 | |
NRG Therapeutics Mitochondrial therapeutics for the treatment of neurodegenerative diseases Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 0 | 5 | 12 | |
TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 0 | 4 | 24 | |
Angiodroid Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 0 | 45 | |
FluoSphera The only company with a suite of systemic and high-throughput in vitro drug discovery solutions FluoSphera S.A. is the only company providing a suite of high-throughput, systemic, in vitro drug discovery solutions. Its proprietary chip-free platform uses flexible 3D cell systems that mimic the complex biology of the human body to rapidly and precisely study human response to systemic drug delivery. FluoSphera offers four distinct drug discovery solutions: (1) multiplexing for target selectivity, (2) measuring systemic efficacy and toxicity, (3) systemic biomarker identification, and (4) translational species optimization. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 0 | 6 | 4 | |
Resalis Therapeutics Tackling metabolic disorders with non-coding RNAs Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 9 |